Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using org 10172

O'Donnell, 1993, Delayed hypersensitivity reaction to heparin, Br J Dermatol, 129, 634, 10.1111/j.1365-2133.1993.tb00502.x

Haram, 1993, Osteopenia caused by heparin treatment in pregnancy, Acta Obstet Gynecol Scand, 72, 674, 10.3109/00016349309021163

Warkentin, 1995, Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin, N Engl J Med, 332, 1330, 10.1056/NEJM199505183322003

King, 1984, Heparin-associated thrombocytopenia, Ann Intern Med, 100, 535, 10.7326/0003-4819-100-4-535

Magnani, 1993, Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172), Thromb Haemost, 70, 554, 10.1055/s-0038-1649626

Henny, 1985, A randomized blind study comparing standard heparin and a new low-molecular-weight heparinoid in cardiopulmonary bypass in dogs, J Lab Clin Med, 196, 187

Doherty, 1990, “Heparin-free” cardiopulmonary bypass: first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass, Anesthesiology, 73, 562, 10.1097/00000542-199009000-00034

Salzman, 1980, Effect of heparin and heparin fractions on platelet aggregation, J Clin Invest, 65, 64, 10.1172/JCI109661

Greinacher, 1991, A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia, Thromb Haemost, 66, 734, 10.1055/s-0038-1646493

Greinacher, 1994, Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen, Thromb Haemost, 71, 247

Cines, 1987, Immune endothelial-cell injury in heparin-associated thrombocytopenia, N Engl J Med, 316, 581, 10.1056/NEJM198703053161004

Sheridan, 1986, A diagnostic test for heparin-induced thrombocytopenia, Blood, 67, 27, 10.1182/blood.V67.1.27.27

Kappa, 1990, Intraoperative management of patients with heparin-induced thrombocytopenia, Ann Thorac Surg, 49, 714, 10.1016/0003-4975(90)90008-T

Munver, 1994, Heparin-induced thrombocytopenia and thrombosis: presentation after cardiopulmonary bypass, Ann Thorac Surg, 58, 1764, 10.1016/0003-4975(94)91686-1

O-Yurvati, 1994, Heparinless cardiopulmonary bypass with ancrod, Ann Thorac Surg, 57, 1656, 10.1016/0003-4975(94)90148-1

Matsuo, 1992, Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor, Br J Haematol, 82, 627, 10.1111/j.1365-2141.1992.tb06482.x

DeAnda, 1994, Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass, Ann Thorac Surg, 58, 344, 10.1016/0003-4975(94)92206-3

Mehta, 1991, Heparin-induced thrombocytopenia and thrombosis: reversal with streptokinase, Am J Hematol, 36, 275, 10.1002/ajh.2830360410

Brady, 1991, Plasmapheresis, Am J Clin Pathol, 96, 394, 10.1093/ajcp/96.3.394

Roussi, 1984, Use of low-molecular-weight heparin in heparin-induced thrombocytopenia with thrombotic complications, Lancet, 1, 1183, 10.1016/S0140-6736(84)91430-2

Massonnet-Castel, 1984, Low-molecular-weight heparin in extracorporeal circulation, Lancet, 8387, 1182, 10.1016/S0140-6736(84)91429-6

Horellou, 1984, Persistent heparin-induced thrombocytopenia despite therapy with low-molecular-weight heparin, Thromb Haemost, 51, 134, 10.1055/s-0038-1661041

Blockmans, 1986, Heparin-induced thrombocytopenia, platelet aggregation studies in the presence of heparin fractions or semi-synthetic analogues of various molecular weights and anti-coagulant activities, Thromb Haemost, 55, 90, 10.1055/s-0038-1661454

Bradbrook, 1987, Org 10172: a low molecular weight anticoagulant with a long half-life in man, Br J Clin Pharmacol, 23, 667, 10.1111/j.1365-2125.1987.tb03100.x

Teien, 1976, Assay of heparin in plasma using a chromogenic substrate for activated factor X, Thromb Res, 8, 413, 10.1016/0049-3848(76)90034-7